Sequencing & GenomicsNext-Generation SequencingRUO

AVENIO Tumor Tissue Targeted Kit V2

By Roche Diagnostics

Product TypeAssay Kit
TechnologyNext-Generation Sequencing
Regulatory StatusRUO

Key takeaways

AVENIO Tumor Tissue Targeted Kit V2 is a product in the Sequencing & Genomics category, manufactured by Roche Diagnostics. Listed regulatory status: RUO (as reported by the manufacturer).

  • Platform: Next-Generation Sequencing
  • Applications: Oncology Markers
AVENIO Tumor Tissue Targeted Kit V2 — Roche Diagnostics product image

Classification

Category
Sequencing & Genomics
Product Type
Assay Kit
Technology
Next-Generation Sequencing

Application

Application Area
Oncology Markers

Regulatory Status

RUO

Reported from manufacturer sources and not independently verified.

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

  • The AVENIO Tumor Tissue Targeted Kit V2 is a next-generation sequencing (NGS) research use only assay for genomic profiling of solid tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.
    Roche DiagnosticsProduct TypeManufacturer Page2026-10-28

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-26

Updated

2026-10-31

Disclaimer

availability varies

Explore more